Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sandvik announces changes to the Group Executive Management

Sandvik has appointed Sofia Sirvell as Chief Digital Officer (CDO) for the Sandvik Group and new member of the Group Executive Management as of March 1, 2023. Sofia Sirvell, born in 1974, is currently Sandvik Group Chief Information Officer (CIO), a position she has held since 2021. Prior to joining Sandvik, she was the Deputy CTO at H&M Group, where she had a leading role in the fashion company’s digital transformation. In the CDO role, she will continue the digital transformation of Sandvik and support collaboration across the Group to enhance digital capabilities and IT. Sofia Sirvell

Concordium and Beatoken partner up to transform the way artists connect with their fans and communities

February 21, 2023 - Zug, Switzerland - Concordium Blockchain announces it is partnering with Beatoken, an innovative social platform that aims to bridge the gap between artists, fans, record labels and streaming services by leveraging the popularity of digital assets and security tokens.With connections to Samsung and Universal as well as a distinctive network in the Danish music industry, Beatoken is a curated marketplace for rare digital music collectables created by the Danish rapper Kesi and associates. The platform provides a new and exciting way for music enthusiasts to engage with

Jessica Alm to join Essity’s Executive Management Team

Hygiene and health company Essity today announced that Jessica Alm will join Essity’s Executive Management Team in the role of Chief Communication Officer.Jessica Alm will join Essity from the industrial company Sandvik, where she has served in various roles over the past 17 years, the past ten of which as Head of Group Communications and as a member of Group Executive Management. She has broad experience of working with brand development, strategic communication and sustainability.  Jessica Alm will succeed Joséphine Edwall Björklund who after ten years in the position, as previously

Pia Baumann takes up her position as Chief Medical Officer

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that the company’s new Chief Medical Officer (CMO) Pia Baumann took up her position. As member of the company's management team her responsibilities include the continued clinical development of the candidate drug fostroxacitabine bralpamide (fostrox).   Pia Baumann, an MD specialized in oncology who earned her Ph.D. at Karolinska Institute, has substantial experience in drug development in the

Breakthrough for Diabetic Foot Screening in Germany – Top-Ranked Diabetes Clinic Purchases VibroSense Meter ® II

The Diabetes Clinic Herz und Diabetescentrum Nordrhein-Westfalen (HDZ NRW) has purchased VibroSense Meter® II and Diabetic Foot Screening after completed evaluation.The clinic has been evaluating VibroSense Meter® II and the application Diabetic Foot Screening with a stated goal of purchasing the instrument after the evaluation is completed, provided that the instrument meets defined requirements. The order value is 16 500 EUR including an annual recurring software license fee of 2000 EUR. The diabetes clinic at HDZ NRW is a highly ranked clinic at the university hospital in Bochum in

Nomination Committee Board Proposals for 2023

To the Annual General Meeting (AGM) on May 10, 2023, the Nomination Committee of Beijer Electronics Group AB has informed the company that it will be proposing following:· that the Board of Directors shall consist of six members. · re-election of Board members Bo Elisson, Johan Wester, Karin Gunnarsson, Lars Eklöf and Jonas Hård. Ulrika Hagdahl has declined re-election. · new election of Charlott Samuelsson. · election of Bo Elisson as Chairman of the Board. Charlott Samuelsson, born 1963, has been employed at Mycronic since 1996 where she is division manager for Pattern

SUBSCRIPTION PERIOD IN THE DANISH TECH-COMET, MEEW A/S, SHARE ISSUE BEGINS TODAY

Today is the first day of the subscription period in MeeW A/S (“MeeW” or the ”Company”) share issue prior to planned listing on Spotlight Stock Market (the “IPO” or the “Offer”). The subscription period runs until 7 March 2023. A fully subscribed Offer will provide MeeW with approx. DKK 18.5 million before transaction related costs. MeeW has received pre-subscription commitments prior to the IPO corresponding to approx. 80 percent of the Offer. Memorandum and a summarized teaser are available at the Company’s (www.meew.dk), SeaHouse Capital ApS’s (www.seahousecapital.dk), and Nordic Issuing

BioStock: Evaxion and Pantherna reach preclinical proof-of-concept

Evaxion Biotech has teamed up with Pantherna Therapeutics to test Evaxion’s AI-driven drug discovery technology in combination with an mRNA vaccine platform. The two biotech partners have announced preclinical proof-of-concept with their combined technologies, demonstrating promising anti-tumour effects.Read the article at biostock.se: Evaxion and Pantherna reach preclinical proof-of-concept - BioStock This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.

Brain+ showcases its digital dementia products at the Danish-Japanese Welfare and Health Tech Business Conference

Copenhagen, Denmark, February 21, 2022 – Brain+ A/S (Nasdaq First North: BRAINP) · Important opportunity for Brain+ to present its innovative digital solutions for better care and treatment of Alzheimer’s and other types of dementia to key Japanese industry and academic stakeholders. · With a large aging population and more than 4.6 million people living with dementia, Japan has a strong focus on new treatment options and represents a highly attractive market opportunity for Brain+.Brain+ is part of a group of Danish welfare and health tech companies that have been invited to

Image Systems' business area RemaSawco receives an order of approx. 3 MSEK from ATA Timber Widtsköfle

RemaSawco AB and ATA Timber Widtsköfle AB have signed an agreement regarding delivery, installation, training and commissioning of RemaSawco's market-leading BoardScanner for the sawmill's green sorter.The agreement includes delivery, installation and commissioning of RemaSawco's market-leading product BoardScannerP for the sawmill's green sorter, where it will be used for dimension- and profile measurement (i.e. wane optimization). RemaSawco will also carry out training of the customer's own staff in two stages, preparatory and during commissioning. "We are very pleased that ATA Timber

Invitation to presentation of Sectra's nine-month interim report 2022/2023

Linköping, Sweden – February 21, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will host a presentation of the company’s nine-month report 2022/2023 with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CET) on March 10, 2023Report presentation: 10:00 a.m. (CET) on the same date Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to info.investor@sectra.com.  To participate,

Professor Bart Meyns Strengthens Realheart's Advisory Board

Press Release 21 February, 2023 The Swedish company Realheart, which is developing the world's first four-chamber artificial heart, is further strengthening its expertise when Belgian surgeon Bart Meyns joins the company's medical advisory board. Dr Meyns is a Professor at the University of Leuven in Belgium and is also leading Realheart's surgical team in the ongoing animal study.Bart Meyns has been President of both the European Society of Artificial Organs, ESAO, and the International Society of Mechanical Circulatory Support, ISMCS, of which Realheart's CEO, Dr Ina Laura Perkins, is

Aquaporin announces successful completion of Offering of new shares in connection with private placement, raising gross proceeds of DKK 74 million

Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694 Company announcementNo. 14/2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND DOES NOT CONSTITUTE A PUBLIC OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.  Kongens Lyngby, Denmark,February 21, 2023– The Board of

Bokslutskommuniké 1 JANUARI – 31 DECEMBER 2022 FLOWSCAPE TECHNOLOGY AB (publ), ORG.Nr. 556725-4866

Styrelsen och verkställande direktören för Flowscape Technology AB avger härmed rapport för perioden januari – december 2022. Belopp anges i tusentals kronor. Siffror inom parentes avser motsvarande period föregående år. This information is only available in swedish.Januari – December i korthet, koncern HELÅRET (JANUARI-DECEMBER) · Omsättningen uppgick till 41 067 (32 962) TSEK · Rörelseresultat före avskrivningar uppgick till -2 364 (1 356) TSEK · Resultat efter finansiella poster uppgick till -25 570 (-22 386) TSEK · Inkomna ordrar uppgick till 26 247 (26 727) TSEK, varav

XNK Therapeutics to present at Redeye’s Regenerative Medicine/Cell Therapy event on February 22

XNK Therapeutics AB’s CEO Johan Liwing will present at Redeye’s Regenerative Medicine/Cell Therapy event on February 22 between 09:00-12:00 CET.XNK’s presentation starts at 09:10 and is followed at 09:55 by a panel discussion regarding cell therapy for cancer. The presentation is broadcasted live starting at 09:00 and can be followed at: https://www.redeye.se/events/868745/redeye-theme-regenerative-medicine-cell-therapy-2 For more information, please contact: Johan Liwing, CEO, XNK Therapeutics Tel: +46 706 70 36 75 E-mail: johan.liwing@xnktherapeutics.com About XNK

BPC Instruments reports fourth quarter and full-year results 2022

BPC Instruments (“BPC” or “the Company”) hereby publishes the year-end report for the period January 1 – December 31, 2022. The year-end report is available as an attached file to this release and on the Company’s website (www.bpcinstruments.com ). Below is a summary of the report.CEO Dr. Jing Liu comments: “As we close the books on the financial year of 2022 we recognize that BPC’s strong growth continued with an impressive net sales increase of +27 percent, amounting to over SEK 33.5 million, compared to SEK 26.4 million in 2021. Our EBIT

The new TANGO XP espresso line launched by UNIC

To continue to take advantage of the fast-growing espresso coffee market, UNIC, part of Electrolux Professional Group, is launching a new range of super-automatic, high-performing espresso machines, the TANGO[®] XP line.The range includes single and double output models and is dedicated to coffee professionals who place high expectations on premium coffee extraction. Philippe Zavattiero, President Business Area Beverage & Food Preparation comments: “In 2019, the Group acquired UNIC to enter the fast-growing espresso coffee market, a trend that today is even stronger. With the launch of

Saab Responds to NATO RFI with GlobalEye

Saab has responded to a Request for Information (RFI) from NATO’s Support and Procurement Agency regarding a new generation of surveillance and control capabilities. Saab’s response is based on GlobalEye.NATO will define its new generation capability within the Alliance Future Surveillance and Control (AFSC) project. “Saab is a proven and trusted part of NATO’s defence industrial base and we are present in more than two thirds of the member nations. Our solutions, including GlobalEye, are from the outset developed to be compliant with NATO’s requirements. I am confident that we can

Year-end Report January-December 2022

Corem Kelly AB, renamed from Klövern AB in 2022, is consolidated in Corem from 15 June 2021.  · Income increased to SEK 4,491 million (2,805).  · Net operating income increased to SEK 2,933 million (1,894).  · Net financial items amounted to SEK –1,071 million (–579), of which dividends from shareholdings amounted to SEK 67 million (106).  · Profit from property management increased to SEK 1,675 million (1,178).  · Changes in value of properties amounted to SEK –2,934 million (3,432).  · Changes in value of financial assets at fair value amounted to SEK –1,

Year-end Report January – December 2022

This year-end report 2022 has been prepared for the purpose of complying with the terms of Corem Kelly AB’s (publ) bond and loan agreements.   On 29 March 2021, Corem Property Group AB (publ) announced a public offer to the shareholders of Klövern AB (publ). Klövern's shares were delisted from Nasdaq Stockholm in July 2021, following a declaration that the offer was unconditional. After a resolution at the Annual General Meeting on 27 April 2022 Klövern AB has been renamed Corem Kelly AB.   JANUARY–DECEMBER 2022 · Income amounted to SEK 3,467 million (3,274).  · Profit

MPC Container Ships: Invitation to Q4 2022 Earnings Call

MPC Container Ships ASA will publish its Q4 2022 financial report on Tuesday, February 28, 2023. Constantin Baack, CEO, and Moritz Fuhrman, CFO, will present the results in an earnings call at 15:00 CET / 09:00 ET on February 28, 2023, followed by a  Q&A session. The earnings call can be accessed live via webcast or conference call and questions can be submitted orally or in writing. A recording of the earnings call will be available on demand at the Company's website after the live event has concluded. The live webcast can be accessed via the following link: https://edge.media-

Embellence Group Interim Report Q4 2022

Continued healthy profitability despite headwind in Nordic demandFourth quarter 2022 · Net sales amounted to MSEK 176.9 (174.0), up 1.7%. Acquisition-based growth of 16.1%, exchange rate effects of 2.1% and organic growth of –16.5% · EBITA amounted to MSEK 14.7 (25.8). · Adjusted EBITA* amounted to MSEK 22.0 (30.4) · Net profit for the period amounted to MSEK 9.9 (18.4), and earnings per share for the period before dilution were SEK 0.44 (0.86) · Operating cash flow amounted to MSEK 16.0 (15.3) Significant events during the quarter · Karin Lidén became new CFO of

Year-end report 1 January – 31 December 2022

Net sales increases with 94 percent and EBITA improves with 96 percentFOURTH QUARTER 2022 · Net sales increased by 94 percent to MSEK 401 (206). In unchanged currency levels, net sales increased by 90 percent. · Operating profit before amortization of intangible assets (EBITA) increased by 96 percent to MSEK 31 (16) including MSEK -0.8 (-0.6) attributable to unrealized exchange rate gains and losses together with MSEK 1.6 (0) attributable to previously set aside contingent consideration for Alcadon Belgium (formerly 6X International BV). · Cash flow from operating activities

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 21, 2023, at 9.00 am EETRepurchase of Outokumpu’s own shares On February 20, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |40,852 |5.5818

There are no items matching the current filter
There are no more items matching the current filter
Back to top